352 related articles for article (PubMed ID: 27398024)
21. Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay.
Zhou H; Peng X; Hou T; Zhao N; Qiu M; Zhang X; Liang X
J Ethnopharmacol; 2020 Jan; 246():112218. PubMed ID: 31494202
[TBL] [Abstract][Full Text] [Related]
22. Bioactive Chemical Composition of Cannabis Extracts and Cannabinoid Receptors.
Yang Y; Vyawahare R; Lewis-Bakker M; Clarke HA; Wong AHC; Kotra LP
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751516
[TBL] [Abstract][Full Text] [Related]
23. Molecular Mechanism and Cannabinoid Pharmacology.
Schurman LD; Lu D; Kendall DA; Howlett AC; Lichtman AH
Handb Exp Pharmacol; 2020; 258():323-353. PubMed ID: 32236882
[TBL] [Abstract][Full Text] [Related]
24. Molecular Targets of the Phytocannabinoids: A Complex Picture.
Morales P; Hurst DP; Reggio PH
Prog Chem Org Nat Prod; 2017; 103():103-131. PubMed ID: 28120232
[TBL] [Abstract][Full Text] [Related]
25. Behavioral effects of cannabinoid agents in animals.
Chaperon F; Thiébot MH
Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
Wilkinson JD; Williamson EM
J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid CB
Spiller KJ; Bi GH; He Y; Galaj E; Gardner EL; Xi ZX
Br J Pharmacol; 2019 May; 176(9):1268-1281. PubMed ID: 30767215
[TBL] [Abstract][Full Text] [Related]
29. Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.
Gamage TF; Farquhar CE; Lefever TW; Marusich JA; Kevin RC; McGregor IS; Wiley JL; Thomas BF
J Pharmacol Exp Ther; 2018 May; 365(2):437-446. PubMed ID: 29549157
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and testing of novel classical cannabinoids: exploring the side chain ligand binding pocket of the CB1 and CB2 receptors.
Nadipuram AK; Krishnamurthy M; Ferreira AM; Li W; Moore BM
Bioorg Med Chem; 2003 Jul; 11(14):3121-32. PubMed ID: 12818675
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
Booker L; Naidu PS; Razdan RK; Mahadevan A; Lichtman AH
Drug Alcohol Depend; 2009 Nov; 105(1-2):42-7. PubMed ID: 19679411
[TBL] [Abstract][Full Text] [Related]
32. Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa.
Radwan MM; ElSohly MA; El-Alfy AT; Ahmed SA; Slade D; Husni AS; Manly SP; Wilson L; Seale S; Cutler SJ; Ross SA
J Nat Prod; 2015 Jun; 78(6):1271-6. PubMed ID: 26000707
[TBL] [Abstract][Full Text] [Related]
33. Cannabis and Neuropsychiatric Disorders: An Updated Review.
Chayasirisobhon S
Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
[TBL] [Abstract][Full Text] [Related]
34. Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells.
Sachdev S; Boyd R; Grimsey NL; Santiago M; Connor M
PeerJ; 2019; 7():e7733. PubMed ID: 31579608
[TBL] [Abstract][Full Text] [Related]
35. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
McPartland JM; Duncan M; Di Marzo V; Pertwee RG
Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544
[TBL] [Abstract][Full Text] [Related]
36. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
Darmani NA; Janoyan JJ; Crim J; Ramirez J
Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
[TBL] [Abstract][Full Text] [Related]
37. Novel cannabinol probes for CB1 and CB2 cannabinoid receptors.
Mahadevan A; Siegel C; Martin BR; Abood ME; Beletskaya I; Razdan RK
J Med Chem; 2000 Oct; 43(20):3778-85. PubMed ID: 11020293
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
DeLong GT; Wolf CE; Poklis A; Lichtman AH
Drug Alcohol Depend; 2010 Nov; 112(1-2):126-33. PubMed ID: 20619971
[TBL] [Abstract][Full Text] [Related]
39. Naturally occurring and related synthetic cannabinoids and their potential therapeutic applications.
Galal AM; Slade D; Gul W; El-Alfy AT; Ferreira D; Elsohly MA
Recent Pat CNS Drug Discov; 2009 Jun; 4(2):112-36. PubMed ID: 19519560
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.
Thomas BF; Adams IB; Mascarella SW; Martin BR; Razdan RK
J Med Chem; 1996 Jan; 39(2):471-9. PubMed ID: 8558515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
